Cancer treatment will reach a new milestone!

The Yonglin Health Foundation, National Taiwan University Hospital, and radiation therapy equipment company Varian signed a memorandum to cooperate among industry, academia, and research institutes to introduce high-tech radiation therapy product research and development technology to promote Taiwan's life sciences industry.

.

The memorandum signed by the Yongling Health Foundation, National Taiwan University Hospital and Varian includes equipment procurement and joint development of new types of treatment equipment; the Yongling Health Foundation will donate the first set of Varian proton therapy equipment to NTU

Cancer Medical Center, which conducts clinical radiotherapy and related research.

The Yongling Health Foundation stated that it will cooperate with Varian in the future. The projects include providing clinical academic research on radiotherapy in the Asia-Pacific region, as well as training, joint research and development of next-generation photon and proton therapy equipment, and expanding into the development of radiotherapy peripheral equipment.

wait.

In the joint research and development of photonic technology, new types of equipment will be created.

The Yongling Health Foundation pointed out that the National Taiwan University Cancer Center Hospital is expected to add cancer clinical services in 2018, cooperate with the newly completed Yongling Biomedical Engineering Center, and combine with Varian, the world's top medical equipment manufacturer, to develop high-tech radiotherapy products.

The introduction of technology to Taiwan and the joint efforts of industry, academia and research to fight cancer can drive Taiwan's life science industry and provide better services in cancer medical treatment.